Dianthus Therapeutics, Inc. · XETR:87E
Dianthus Therapeutics, Inc. shareholders
As of Sep 30, 2026, 267 institutions reported holding Dianthus Therapeutics, Inc. Largest: Fidelity, T. Rowe Price and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Dianthus Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Fidelity | 8.55M | +353K | Nov 10, 2026 | |
| T. Rowe Price | 8.09M | +1.69M | Nov 16, 2026 | |
| Vanguard | 4.44M | +1.35M | Nov 16, 2026 | |
| BlackRock | 4.39M | +266K | Nov 13, 2026 | |
| Wellington | 3.01M | −224K | Nov 16, 2026 | |
| Fairmount Funds Management LLC | 2.54M | no change | Nov 16, 2026 | |
| State Street | 2.53M | +177K | Nov 12, 2026 | |
| Avidity Partners Management LP | 1.9M | −205K | Nov 16, 2026 | |
| Octagon Capital Advisors LP | 1.69M | −155K | Nov 16, 2026 | |
| TCG Crossover Management, LLC | 1.68M | no change | Nov 16, 2026 |